GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Packaging & Containers » Touyun Biotech Group Ltd (HKSE:01332) » Definitions » 5-Year ROIIC %

Touyun Biotech Group (HKSE:01332) 5-Year ROIIC % : -27.21% (As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Touyun Biotech Group 5-Year ROIIC %?

5-Year Return on Invested Incremental Capital (5-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 5-year. Touyun Biotech Group's 5-Year ROIIC % for the quarter that ended in Dec. 2023 was -27.21%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Touyun Biotech Group's 5-Year ROIIC % or its related term are showing as below:

HKSE:01332's 5-Year ROIIC % is ranked worse than
85.03% of 374 companies
in the Packaging & Containers industry
Industry Median: 3.845 vs HKSE:01332: -27.21

Touyun Biotech Group 5-Year ROIIC % Historical Data

The historical data trend for Touyun Biotech Group's 5-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Touyun Biotech Group 5-Year ROIIC % Chart

Touyun Biotech Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
5-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -7.92 14.35 186.41 -84.71 -27.21

Touyun Biotech Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
5-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 186.41 - -84.71 - -27.21

Competitive Comparison of Touyun Biotech Group's 5-Year ROIIC %

For the Packaging & Containers subindustry, Touyun Biotech Group's 5-Year ROIIC %, along with its competitors' market caps and 5-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Touyun Biotech Group's 5-Year ROIIC % Distribution in the Packaging & Containers Industry

For the Packaging & Containers industry and Consumer Cyclical sector, Touyun Biotech Group's 5-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Touyun Biotech Group's 5-Year ROIIC % falls into.



Touyun Biotech Group 5-Year ROIIC % Calculation

Touyun Biotech Group's 5-Year ROIIC % for the quarter that ended in Dec. 2023 is calculated as:

5-Year ROIIC %=5-Year Incremental Net Operating Profit After Taxes (NOPAT)**/5-Year Incremental Invested Capital**
=( -86.971302 (Dec. 2023) - -145.6879134 (Dec. 2018) )/( 660.006 (Dec. 2023) - 875.806 (Dec. 2018) )
=58.7166114/-215.8
=-27.21%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 5-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Touyun Biotech Group  (HKSE:01332) 5-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Touyun Biotech Group 5-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Touyun Biotech Group's 5-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Touyun Biotech Group (HKSE:01332) Business Description

Traded in Other Exchanges
N/A
Address
6 Tonnochy Road, 12th Floor, Kwan Chart Tower, Wanchai, Hong Kong, HKG
Touyun Biotech Group Ltd, formerly China Touyun Tech Group Ltd, an investment holding company, designs, develops, manufactures, and sells packaging products and point-of-sales display units. It operates with four business segments, Packaging Products, Treasury Investment, QR code business, and Chlamydomonas reinhardtii product business. Through the Packaging Products segment, it offers watch boxes, jewelry boxes, eyewear cases, bags and pouches, and display units whereas the Treasury segment engages in the trading of securities and money lending activities. It derives a majority of its revenue from the Packaging products. The business activity of the group is operated in Hong Kong, Mainland China, North and South America, and other countries.
Executives
Wang Liang 2101 Beneficial owner
Tian Yuze 2101 Beneficial owner
Tian Yuze 2101 Beneficial owner
Qiao Yanfeng 2201 Interest of corporation controlled by you
Qin Fen 2101 Beneficial owner

Touyun Biotech Group (HKSE:01332) Headlines

No Headlines